Showing results (571-580 of 3,096) with videos related to
Sort By:
Pageof 310
Expert Review of Anticancer Therapy|March 30, 2026
Can we consider stopping hepatocellular carcinoma surveillance in low-risk patients with hepatitis B?Nicole J Kim, H Nina Kim, Brian J McMahon, et al.Expert Review of Anticancer Therapy|May 15, 2026
Bladder-preserving trimodality therapy for muscle-invasive bladder cancer: current state-of-the-artCatherine Fahey, Shivani Sud, Anvitha Remella, et al.Expert Review of Anticancer Therapy|December 17, 2016
Intra-arterial therapies for liver cancer: assessing tumor responseYasmin W Stroehl, Brian S Letzen, Johanna M M van Breugel, et al.Expert Review of Anticancer Therapy|December 18, 2016
From chemotherapy to target therapies associated with radiation in the treatment of NSCLC: a durable marriage?Filippo Alongi, Stefano Arcangeli, Sara Ramella, et al.Expert Review of Anticancer Therapy|November 15, 2016
Targeting reactive oxygen species in development and progression of pancreatic cancerNisha Durand, Peter StorzExpert Review of Anticancer Therapy|January 4, 2017
How clinical practice is changing the rules: the sunitinib 2/1 schedule in metastatic renal cell carcinomaSergio Bracarda, Sylvie Negrier, Jochen Casper, et al.Expert Review of Anticancer Therapy|June 7, 2008
Molecular pathology and potential therapeutic targets in soft-tissue sarcomaRadha Todd, John LunecExpert Review of Anticancer Therapy|June 7, 2008
Novel advances in pancreatic cancer treatmentMichel Vulfovich, Caio Rocha-LimaExpert Review of Anticancer Therapy|April 18, 2014
Pomalidomide for the treatment of relapsed-refractory multiple myeloma: a review of biological and clinical dataMassimo Offidani, Laura Corvatta, Patrizia Caraffa, et al.Expert Review of Anticancer Therapy|May 8, 2014
Helicobacter pylori and the molecular pathogenesis of intestinal-type gastric carcinomaKatsuhiro Hanada, David Y GrahamPageof 310